| Amneet Virk Dulai, MD | |
|
7082 N Maple Ave Ste 101, Fresno, CA 93720-8004 | |
| (559) 449-0331 | |
| (559) 449-0246 |
| Full Name | Amneet Virk Dulai |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 23 Years |
| Location | 7082 N Maple Ave Ste 101, Fresno, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992911309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | A117190 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Regional Medical Center | Fresno, CA | Hospital |
| Saint Agnes Medical Center | Fresno, CA | Hospital |
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Entity Name | California Rheumatology And Wellness, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134561400 PECOS PAC ID: 9335371582 Enrollment ID: O20140422001912 |
News Archive
Molecular dermatology research and development innovator DermaGenoma, Inc. today released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients' risk for developing frequent Genital Herpes (HSV-2) outbreaks.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today an agreement with Dell to market and deliver advanced technology solutions and services to medical practices of all sizes, rural and community hospitals and physician networks.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Portuguese scientists identified a molecular mechanism that can lead to metastases (spread of the cancer from the original site to other remote parts of the body) in breast cancers. Abnormally high levels of P-cadherin - an adhesion molecule that enables cells to bind together - occur in about a third of all breast cancers and are associated with poor prognosis.
A team of researchers at the University of Manitoba in Canada said that nanoparticle targeting of autophagy at the sites could be a potent tool to effectively overcome COVID-19 while preventing the common adverse effects of the drug.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amneet Virk Dulai, MD Po Box 28915, Fresno, CA 93729-8915 Ph: (559) 253-2800 | Amneet Virk Dulai, MD 7082 N Maple Ave Ste 101, Fresno, CA 93720-8004 Ph: (559) 449-0331 |
News Archive
Molecular dermatology research and development innovator DermaGenoma, Inc. today released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients' risk for developing frequent Genital Herpes (HSV-2) outbreaks.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today an agreement with Dell to market and deliver advanced technology solutions and services to medical practices of all sizes, rural and community hospitals and physician networks.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Portuguese scientists identified a molecular mechanism that can lead to metastases (spread of the cancer from the original site to other remote parts of the body) in breast cancers. Abnormally high levels of P-cadherin - an adhesion molecule that enables cells to bind together - occur in about a third of all breast cancers and are associated with poor prognosis.
A team of researchers at the University of Manitoba in Canada said that nanoparticle targeting of autophagy at the sites could be a potent tool to effectively overcome COVID-19 while preventing the common adverse effects of the drug.
› Verified 6 days ago
Maulik Shah, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4555 | |
Rami Alrezk, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 155 N Fresno St, Fresno, CA 93701 Phone: 559-499-6479 | |
Dr. John R Nelson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7061 N Whitney, Suite 101, Fresno, CA 93720 Phone: 559-299-0224 Fax: 559-299-4201 | |
Dexter T Estrada, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7130 N Millbrook Ave Ste 100, Fresno, CA 93720 Phone: 559-326-1222 Fax: 559-326-1230 | |
Dr. Sherry Lopez, D.O. Rheumatology Medicare: Medicare Enrolled Practice Location: 3209 W Shaw Ave, Suite 114, Fresno, CA 93711 Phone: 559-224-4977 Fax: 559-224-4980 | |
Maria Flordeliz Arambulo, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6484 Fax: 559-499-6501 | |
Shreela Mishra, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7085 N Chestnut Ave Ste 101, Fresno, CA 93720 Phone: 559-323-9236 Fax: 559-323-0294 |